Provectus Biopharmaceuticals Inc (PVCT)
0.195
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Provectus Biopharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2014 | -0.0706M |
| September 30, 2014 | -0.0706M |
| June 30, 2014 | -0.0067M |
| March 31, 2014 | -0.0067M |
| December 31, 2013 | -0.0067M |
| September 30, 2013 | -0.0067M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.0159M |
| September 30, 2012 | -0.0159M |
| June 30, 2012 | -0.0159M |
| March 31, 2012 | -0.022M |
| December 31, 2011 | -0.0061M |
| September 30, 2011 | -0.0061M |
| June 30, 2011 | -0.0061M |
| March 31, 2011 | 0.00 |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | 4.014M |
| Date | Value |
|---|---|
| September 30, 2008 | 3.348M |
| June 30, 2008 | 1.853M |
| March 31, 2008 | 1.971M |
| December 31, 2007 | -0.2563M |
| September 30, 2007 | -2.644M |
| June 30, 2007 | -1.897M |
| March 31, 2007 | -4.370M |
| December 31, 2006 | -6.339M |
| September 30, 2006 | -4.380M |
| June 30, 2006 | -4.434M |
| March 31, 2006 | -2.481M |
| December 31, 2005 | -0.014M |
| September 30, 2005 | -0.0118M |
| June 30, 2005 | -0.0118M |
| March 31, 2005 | -0.0105M |
| December 31, 2004 | -0.0004M |
| September 30, 2004 | -0.0004M |
| June 30, 2004 | -0.0004M |
| March 31, 2004 | 0.1796M |
| December 31, 2003 | 0.1767M |
| September 30, 2003 | 0.353M |
| June 30, 2003 | 0.353M |
| March 31, 2003 | 0.173M |
| December 31, 2002 | 0.1763M |
| September 30, 2002 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed Inc | -223.60M |
| NeuroMetrix Inc | 1.156M |
| Intra-Cellular Therapies Inc | 105.54M |
| Rhythm Pharmaceuticals Inc | -5.665M |
| Amylyx Pharmaceuticals Inc | 92.05M |